Skip to main content
. Author manuscript; available in PMC: 2011 Jul 12.
Published in final edited form as: Vaccine. 2010 May 21;28(31):5017–5022. doi: 10.1016/j.vaccine.2010.05.018

Fig. 6.

Fig. 6

Protection of mice immunized i.m. with hexavalent, hexavalent+J14 and J14-KLH after i.n. challenge with type 24 GAS. Groups of 15 mice each were immunized i.m. with 30μg of the indicated vaccine at time 0, 3, 6 and 9 weeks. Three weeks after the final immunization, the mice were challenged via the i.n. route with 2.4 × 107 CFU of type 24 GAS.